IMMUNOGENICITY AND SAFETY PROFILES OF GENETIC VACCINES AGAINST HUMAN HER-2/NEU IN CYNOMOLGUS MONKEYS

被引：0
|
作者：
Ko, Hyun-Jeong [1 ]
Kim, Yeon-Jeong [1 ]
Kim, Yun-Sun [1 ]
Kim, Jong-Mook [2 ]
Ho, Seong-Huyn [2 ]
Jeong, Jae-Gyun [2 ]
Oh, Sung-Min [2 ]
Chae, Jin-A [2 ]
Kim, Choong-Yong [3 ]
Lee, Pill Soo [3 ]
Kang, Chang-Yuil [1 ]
机构：
[1] Seoul Natl Univ, Coll Pharm, Inst Pharmaceut Sci, Immunol Lab, Seoul 151742, South Korea
[2] ViroMed Co Ltd, Seoul 151818, South Korea
[3] Korea Inst Toxicol, Div Nonclin Studies, Taejon 305600, South Korea
来源：
JOURNAL OF GENE MEDICINE | 2009年 / 11卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1190 / 1190
页数：1
相关论文
共 50 条
  • [21] Low effectiveness of DNA vaccination against HER-2/neu in ageing
    Provinciali, M
    Smorlesi, A
    Donnini, A
    Bartozzi, B
    Amici, A
    VACCINE, 2003, 21 (9-10) : 843 - 848
  • [22] Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo
    Gritzapis, Angelos D.
    Mahaira, Louisa G.
    Perez, Sonia A.
    Cacoullos, Nike T.
    Paparnichail, Nhchael
    Baxevanis, Constantin N.
    CANCER RESEARCH, 2006, 66 (10) : 5452 - 5460
  • [23] Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours
    DiGiovanna, MP
    Carter, D
    Flynn, SD
    Stern, DF
    BRITISH JOURNAL OF CANCER, 1996, 74 (05) : 802 - 806
  • [24] Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER-2/neu in a murine mammary carcinoma model
    Eralp, Y
    Wang, X
    Wang, JP
    Maughan, MF
    Polo, JM
    Lachman, LB
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S246 - S247
  • [25] Improved immunogenicity of an immunodominant epitope of the Her-2/neu protooncogene by alterations of MHC contact residues
    Vertuani, S
    Sette, A
    Sidney, J
    Southwood, S
    Fikes, J
    Keogh, E
    Lindencrona, JA
    Ishioka, G
    Levitskaya, J
    Kiessling, R
    JOURNAL OF IMMUNOLOGY, 2004, 172 (06): : 3501 - 3508
  • [26] MicroRNA expression profiles predict HER-2/neu oncoprotein and EGF receptor status of human breast cancer
    Wittliff, James
    Kerr, D. Alan
    Brooks, Mason
    Krissinger, Daniel
    Landers, Mark
    Adams, Christopher
    CANCER RESEARCH, 2009, 69
  • [27] HER-2/neu signal transduction in human breast and ovarian cancer
    Reese, DM
    Slamon, DJ
    STEM CELLS, 1997, 15 (01) : 1 - 8
  • [28] HER-2/NEU AND FIBRINOLYTIC FACTORS IN HUMAN BREAST-CANCER
    TOMMASI, S
    RELLA, C
    GIANNELLA, C
    QUARANTA, M
    SCHITTULLI, F
    PARADISO, A
    COVIELLO, M
    DELENA, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (03) : 473 - 477
  • [29] STUDIES OF THE HER-2 NEU PROTOONCOGENE IN HUMAN BREAST-CANCER
    SLAMON, DJ
    PRESS, MF
    GODOLPHIN, W
    RAMOS, L
    HARAN, P
    SHEK, L
    STUART, SG
    ULLRICH, A
    MOLECULAR DIAGNOSTICS OF HUMAN CANCER, 1989, 7 : 371 - 384
  • [30] Overexpression of her-2/neu in human prostate cancer and benign hyperplasia
    Gu, KF
    MesMasson, AM
    Gauthier, J
    Saad, F
    CANCER LETTERS, 1996, 99 (02) : 185 - 189
12345